A Decade of Specialized Care in Kansas City
Dr. Irfan Handoo stands among the first 300 practitioners in the United States to offer intravenous (IV) ketamine treatments, a practice he began in 2016. As the first physician to provide this intervention in the Kansas City area, he has now completed more than 8,000 individual sessions over the past decade. His work recently earned him a seat on the Expert Faculty of the American Society of Ketamine Physicians, a distinction held by only 25 doctors across the country.
The medical field continues to monitor how these treatments affect patients with chronic mental health struggles. Dr. Handoo focuses on cases that have often proven resistant to traditional psychiatric medications. The therapy involves controlled infusions administered in a clinical setting, aimed at addressing symptoms for individuals who find no relief through standard pharmaceuticals.
Patient Perspective and Clinical Outcomes
One recent success story involves a 24-year-old woman named Karlie. She struggled with depression and anxiety for a decade, with symptoms appearing when she was 14 years old. Her condition eventually became so severe that she found herself unable to leave her home, trapping her in a cycle of social withdrawal and personal distress.
Karlie completed a series of IV ketamine treatments in February 2026. Since finishing the protocol, she reports a significant shift in her daily life. Her case is part of a larger trend where patients seek alternatives when standard treatments fail to provide results. By working directly with Dr. Handoo at Kansas City Psychiatry Partners, she managed to break the pattern that had defined her teenage and young adult years.
Understanding the Treatment Landscape
Ketamine infusion therapy functions differently than daily oral medications. It targets specific neurotransmitter receptors to attempt a reset of mood pathways. Because it is administered under direct supervision, physicians can adjust dosages based on the patient's immediate response. The clinical protocol remains precise, requiring ongoing monitoring to ensure safety and efficacy.
While the medical community gathers more data on long-term impacts, the immediate results for many patients appear positive. It is important to look at this as an option for those who have exhausted all other avenues. The role of specialized clinics has grown as awareness of treatment-resistant mental health conditions rises. Dr. Handoo’s appointment to the national faculty suggests that the protocols used in Kansas City meet high standards within this medical sub-specialty. Patients seeking information on this approach often start by scheduling consultations to determine if they meet the clinical criteria for this specific type of care.